Apax acquires majority shareholding in metaGen
With E42m from Apax in the bank, the biotech company will continue to develop new strategies for cancer therapy.
With E42m from Apax in the bank, the biotech company will continue to develop new strategies for cancer therapy.
Copyright PEI Media
Not for publication, email or dissemination